These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17388716)

  • 1. Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: a randomized double-blind pilot study.
    Huertas D; López-Ibor Aliño JJ; Molina JD; Chamorro L; Balanza J; Jiménez MP; Hornillos M
    J Clin Psychiatry; 2007 Mar; 68(3):439-44. PubMed ID: 17388716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproterone to treat aggressivity in dementia: a clinical case and systematic review.
    Bolea-Alamanac BM; Davies SJ; Christmas DM; Baxter H; Cullum S; Nutt DJ
    J Psychopharmacol; 2011 Jan; 25(1):141-5. PubMed ID: 19942637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary pilot study of cyproterone acetate for the treatment of aggressive behavior associated with severe dementia].
    Caparros-Lefebvre D; Dewailly D
    Rev Neurol (Paris); 2005 Nov; 161(11):1071-8. PubMed ID: 16288172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible antiaggressive effect of cyproterone acetate.
    Thibaut F; Kuhn JM; Colonna L
    Br J Psychiatry; 1991 Aug; 159():298-9. PubMed ID: 1837749
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
    Devanand DP; Marder K; Michaels KS; Sackeim HA; Bell K; Sullivan MA; Cooper TB; Pelton GH; Mayeux R
    Am J Psychiatry; 1998 Nov; 155(11):1512-20. PubMed ID: 9812111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    Irani J; Salomon L; Oba R; Bouchard P; Mottet N
    Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.
    De Deyn PP; Rabheru K; Rasmussen A; Bocksberger JP; Dautzenberg PL; Eriksson S; Lawlor BA
    Neurology; 1999 Sep; 53(5):946-55. PubMed ID: 10496251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
    Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
    J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment.
    Allain H; Dautzenberg PH; Maurer K; Schuck S; Bonhomme D; Gérard D
    Psychopharmacology (Berl); 2000 Mar; 148(4):361-6. PubMed ID: 10928308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.
    Herrmann N; Gauthier S; Boneva N; Lemming OM;
    Int Psychogeriatr; 2013 Jun; 25(6):919-27. PubMed ID: 23472619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.
    Dorevitch A; Katz N; Zemishlany Z; Aizenberg D; Weizman A
    Am J Psychiatry; 1999 Jan; 156(1):142-4. PubMed ID: 9892313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproterone acetate in the treatment of aggression.
    Thibaut F; Colonna L
    Am J Psychiatry; 1992 Mar; 149(3):411. PubMed ID: 1531581
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial.
    Verhey FR; Verkaaik M; Lousberg R;
    Dement Geriatr Cogn Disord; 2006; 21(1):1-8. PubMed ID: 16244481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.
    Carlyle W; Ancill RJ; Sheldon L
    Int Clin Psychopharmacol; 1993; 8(2):103-8. PubMed ID: 8345158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
    Cummings JL; Lyketsos CG; Peskind ER; Porsteinsson AP; Mintzer JE; Scharre DW; De La Gandara JE; Agronin M; Davis CS; Nguyen U; Shin P; Tariot PN; Siffert J
    JAMA; 2015 Sep 22-29; 314(12):1242-54. PubMed ID: 26393847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.